Biotech · Private company · Richmond Hill, NY, US
iHealthScreen Inc
Track this companyFree. Adds iHealthScreen Inc to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- No interventionDiabetesClinicalTrials.gov · fetched Nov 12, 2026
- No intervention.Age-related Macular Degeneration (AMD)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Pivotal Trial of Automated Artificial Intelligence (AI) Based System for Early Diagnosis of Diabetic RetinopathyCOMPLETED · started Jan 1, 2025ClinicalTrials.gov NCT07151001 · fetched Nov 12, 2026
- Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular DegenerationRECRUITING · started Aug 1, 2024ClinicalTrials.gov NCT07084883 · fetched Nov 12, 2026
- Automated AI-based System for Early Diagnosis of Diabetic RetinopathyUNKNOWN · started Apr 18, 2022ClinicalTrials.gov NCT05324189 · fetched Nov 12, 2026
NIH awards4
- A Model for Predicting 2-Year Risk of Incident Late Age-related Macular DegenerationFiscal year 2026 · $100KNIH RePORTER 3R44EY031202-06S1 · fetched Nov 12, 2026
- A Model for Predicting 2-Year Risk of Incident Late Age-related Macular DegenerationFiscal year 2026 · $698KNIH RePORTER 5R44EY031202-06 · fetched Nov 12, 2026
- A Model for Predicting 2-Year Risk of Incident Late Age-related Macular DegenerationFiscal year 2025 · $698KNIH RePORTER 5R44EY031202-05 · fetched Nov 12, 2026
- A Model for Predicting 2-Year Risk of Incident Late Age-related Macular DegenerationFiscal year 2024 · $1MNIH RePORTER 2R44EY031202-04A1 · fetched Nov 12, 2026